Replies to post #114789 on Biotech Values

[masterlongevity]

What are your thoughts on the eventual commercial success of VEGF-TRAP?

the results are virtually identical to Lucentis at every 4 wk dosing, and my guss is that they would b idential at every 8 wk dosing ass well (although there is no every 8 wk dosing Lucentis trial)
Lucentis will have a 4 yr market advantage

+ Avastin results are also nearly identical and it is quickly becoming market leader for a price of <$500/yr